SCHEMBL5151095

SCHEMBL5151095

Nc1snc(Cc2ccco2)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.36
MAPK1 P28482 2/20 0.36
HTT P42858 2/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 1/20 0.36
BLM P54132 1/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
PNP P00491 3/20 0.36
GAA P10253 1/20 0.36
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
ALDH1A1 P00352 3/20 0.33
USP2 O75604 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154593 0.71 PNP (0.37) SMN1; SMN2KMT2AKDM4EMAPTMAPK1
SCHEMBL5153970 0.71 PIK3CD (0.40) LMNAPNPADORA3ADORA1
SCHEMBL8834668 0.69 ALDH1A1 (0.41) SMN1; SMN2KMT2AKDM4EMAPTMAPK1
SCHEMBL1404275 0.69 CHRM2 (0.46) KMT2AKDM4EMAPTMEN1GAA
SCHEMBL5154328 0.67 MAPT (0.50) KMT2AKDM4EMAPTMEN1LMNA
SCHEMBL30317218 0.65 NCF1 (0.37) SMN1; SMN2KMT2AKDM4EMAPTMAPK1
SCHEMBL1498698 0.65 PNP (0.44) KMT2AKDM4EMAPTMAPK1MEN1
SCHEMBL27631587 0.65 PNP (0.37) MAPTPNPGAAADORA3ADORA2A
SCHEMBL9387184 0.64 GAA (0.40) KMT2AKDM4EMEN1PNPGAA
SCHEMBL14713173 0.63 HSD17B10 (0.40) SMN1; SMN2KMT2AKDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7297168-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-11-20 US claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
US-7297168-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2007-11-20 US disclosed
EP-1737417-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-01-03 EP disclosed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US disclosed
WO-2005074875-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, CYB5R3 SMN1; SMN2 4850/4885KMT2A 1179/4885KDM4E 756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.